New app aims to cure insomnia from your phone
NCT ID NCT07289217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a mobile app called SleepQ can reduce insomnia symptoms in adults. The app provides a 12-week digital cognitive behavioral therapy program, including sleep scheduling and relaxation techniques. Eighty participants will be randomly assigned to use the app plus usual care, or just usual care alone. The main goal is to see if the app improves sleep quality after 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SleepQ digital cognitive behavioral therapy (dCBT-I) mobile app
What this could lead to
If it works, this could offer a convenient, app-based treatment option for insomnia that people can use from home.
What could go wrong
This is a small pilot trial with only 80 participants, so results may not apply to everyone. The app requires an iPhone with iOS 18 and German language skills, limiting who can use it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Berlin Medical Association (Ärztekammer Berlin)
Berlin, 10969, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••